Special Issue: "Gastrointestinal Cancers and Personalized Medicine"
- PMID: 35330338
- PMCID: PMC8953463
- DOI: 10.3390/jpm12030338
Special Issue: "Gastrointestinal Cancers and Personalized Medicine"
Abstract
Gastrointestinal cancers represent more than 25% of all diagnosed cancers and more than 36% of cancer-related deaths worldwide [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Baraniskin A., Van Laethem J.L., Wyrwicz L., Guller U., Wasan H.S., Matysiak-Budnik T., Gruenberger T., Ducreux M., Carneiro F., Van Cutsem E., et al. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona. Eur. J. Cancer. 2017;86:305–317. doi: 10.1016/j.ejca.2017.09.021. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
